The RIPA-G:2 was normed on 229 individuals from 55 to 97 years old, matched to the prevalence of cognitive disorders in the elderly population and including both normally functioning adults and those with mild cognitive impairment, mild to moderate Alzheimer's disease, right cerebrovascular accident, and traumatic brain injury. Statistical analysis indicated consistently high reliability and validity.